^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
AFM11
i
Other names: AFM11, AFM11 TandAb, CD19 x CD3 TandAb
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Affimed
Drug class:
CD3 agonist, CD19 inhibitor
Related drugs:
over1year
Safety of AFM11 in the treatment of patients with B-cell malignancies: findings from two phase 1 studies. (PubMed, Trials)
AFM11 treatment was associated with frequent neurological adverse reactions that were severe in some patients. In ALL, some signs of activity, albeit short-lived, were observed whereas no activity was observed in patients with NHL; therefore, further clinical development was terminated.
P1 data • Journal
|
CD19 (CD19 Molecule)
|
CD19 positive
|
AFM11
Share via
